William Curtis Reinhold

Title: William Curtis Reinhold: Advancing Research on Triple-Negative Breast Cancer.

Introduction

William Curtis Reinhold is an inventor associated with Rockville, Maryland. His patent work addresses potential treatment approaches for triple-negative breast cancer, an area of significant medical research.

Latest Patents

Reinhold is associated with 1 patent, titled “Method of Treating Triple-Negative Breast Cancer.” The disclosure describes administering oxyphenisatin, oxyphenisatin acetate, or bisacodyl, including pharmaceutically acceptable salts or hydrates, as a potential treatment. It also discusses combining oxyphenisatin or bisacodyl with other active agents and assessing whether a patient may respond to treatment.

Career Highlights

Reinhold’s listed organizational affiliations include Dana-Farber Cancer Institute, Inc., and the United States Department of Health and Human Services. His patent-related work reflects research into possible therapeutic strategies and patient responsiveness in triple-negative breast cancer.

Collaborations

His listed coworkers include Yves Pommier and Vinodh Nalin Rajapakse.

Conclusion

William Curtis Reinhold’s patent focuses on potential drug-based approaches to treating triple-negative breast cancer, including combination therapies and methods for evaluating patient response.